Background: The Pediatric Ulcerative Colitis Activity Index (PUCAI) is a noninvasive clinician-based index, which reflects disease severity in pediatric ulcerative colitis (UC) when no endoscopy is performed. Here, we aimed to explore signs and symptoms important to children with UC and their caregivers as the first stage of developing a patient-reported outcome (PRO) measure for pediatric UC (ie, the TUMMY-UC index) to supplement endoscopic assessment. Methods: Concept elicitation qualitative interviews were performed with children who have UC and their caregivers in 6 centers. Items were rankordered by the interviewees according to the frequency of endorsement and importance, graded on a 1 to 5 scale. Results: A total of 46 children (ages 12.5 AE 3.3 years, range 7-18, 48% boys, 83% with pancolitis, 24% with moderate-severe disease) and 33 caregivers were interviewed (ie, 79 interviews). The following items were identified by the children, in decreasing order of weights: abdominal pain (importance Â frequency weight 3.9), rectal bleeding (3.6), stool frequency (3.0), stool consistency (3.0), general well-being/fatigue (2.9), urgency (1.9), and nocturnal stools (1.6). Two other items were scored lower: lack of appetite (1.1) and weight loss (0.6). Children 13 to 18 years comprehended adult vocabulary, children 8 to 12 years comprehended simple vocabulary, and younger children had poor understanding in completing the questions. Conclusions: In this first stage of the TUMMY-UC development, items were generated and ranked by input from patients. These items are now being explored for optimal vocabulary and response options. The TUMMY-UC will supplement the PUCAI in clinical trial outcome assessment.
T he Pediatric Ulcerative Colitis Activity Index (PUCAI) is a weighted 6-item noninvasive index that has been developed and validated for pediatric ulcerative colitis (UC). Its aim is to reflect as closely as possible the degree of mucosal inflammation because
What Is Known
The Pediatric Ulcerative Colitis Activity Index is a physician-reported outcome, which reflects endoscopic activity in ulcerative colitis. Regulatory agencies require a patient-reported outcome to be completed with endoscopic assessment in inflammatory bowel disease trials.
What Is New
In the first stage of developing a patient-reported outcome for pediatric ulcerative colitis (TUMMY-UC), we performed 79 concept elicitation qualitative interviews with children with ulcerative colitis and their caregivers. Several items were identified as being important and frequent by the children. The identified concepts will now be explored to finalize the exact wording of the TUMMY-UC.
repeated endoscopic evaluation in children is not always feasible both in the clinical and research settings. Its development and validation reflected this aim using physicians' input and colonoscopic data (1) . Since its introduction, the high psychometric characteristics of the PUCAI have been successfully replicated in several cohorts (2) (3) (4) (5) (6) (7) . It has shown high correlation with the endoscopic degree of inflammation in the range of 0.75 to 0.8 (1, 5, 8) . Similarly, PUCAI-defined remission closely reflects endoscopic healing, as shown in 3 studies, with 80% to 90% accuracy (9) (10) (11) .
Recent regulatory guidance requires the use of a patientreported outcome (PRO) measure, which captures signs and symptoms, scored with endoscopic assessment (12) . A PRO is a health status report that comes directly from the patient, without interpretation of the response by an observer (12) . An observer-reported outcome may be used for the youngest age group of children who cannot reliably complete questionnaires. The development should ensure standardization in measurement and age-appropriate interviewer script (13) . It mandates direct patients' input in generating items important to them and not necessarily reflecting the degree of inflammation or biological disease burden. Thus, a PRO measure is different to the concept of disease activity (captured by the PUCAI) and from quality of life (captured by the IMPACT questionnaire in children), each tapping a separate aspect of outcome measurement.
We aimed to develop a PRO for capturing signs and symptoms important to children with UC, termed the TUMMY-UC index. The TUMMY-UC is intended to be discriminative and evaluative over time for use in pediatric UC clinical trials. The TUMMY-UC will supplement the PUCAI, thereby providing 2 scores: one reflecting inflammatory activity and the other allowing assessment of signs and symptoms important to patients. We also aimed to define the age cutoffs for which different questionnaires' versions should be developed. The TUMMY-UC is developed under the qualification process of both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) with multiple iterative revisions.
METHODS
This was a multicenter, multicultural cross-sectional study of concept elicitation interviews, for item generation and reduction of the TUMMY-UC scale. Eligible subjects were children 4 to 18 years with confirmed diagnosis of UC by accepted criteria (14) ; caregivers of the eligible children were interviewed independently.
An interview script was developed for cognitive and qualitative semi-structured interviews performed by trained personnel well experienced with pediatric inflammatory bowel disease (IBD) and in interviewing children (range 3-10 years of experience). Several teleconferences were held by the social worker from the coordinator center in Jerusalem (AN who has 7 years of experience in cognitive interviews) with the interviewers to ensure standardization. In all interviews, data were collected directly from the children and separately from their caregivers. We aimed at a wide variety of ages, disease activity states, and cross-cultural diversity, by performing the interviews in several sites in Israel, Ireland, England, Canada, and United States. Script has been developed in English, the language used for most interviews. Israel was the only center in which interviews were performed in Hebrew following double translation by AN and DT. Basic demographics, disease phenotype, and severity were captured from participants, caregivers, and physicians on standardized case report forms. Disease activity was captured using the PUCAI (remission <10 points, mild disease 10-34 points, moderate disease 35-64 points, and severe !65 points) and by physician, caregiver, and patient global assessment of disease activity (physician global assessment [PGA] , caregiver global assessment [CGA] , and patient global assessment [PaGA], respectively) on a 100-mm visual analogue scale.
Description of the Interviews
The interviews were based on the narrative-biographic approach, which refers to the examinee's point of view. This narrative approach captures the emotion of the moment described, rendering the event active rather than passive, infused with the latent meaning being communicated by the teller. We probed how children with UC experience the signs and symptoms of their disease. We utilized a discourse analysis in which children express their perception to their illness through the language. The interviews attempted to understand the children's and caregivers' terminology and how they describe ''good days'' and ''bad days'' in terms of their colitis. They were asked to specify 5 signs and symptoms best reflecting their colitis when it is acting up. Children were then probed for items identified based on previous literature, but these replies were not included in the frequency scoring (which was calculated based on symptoms raised spontaneously by the children). Next, children were asked to grade each identified item as 1 (least important) to 5 (most important). One caregiver was asked to be interviewed independently to highlight differences from the child's perspective and to describe behaviors of younger children (eg, ''describe how your child behaves when he has mild or severe tummy pain?''). These data were used to base a TUMMY-UC version for the youngest age group that cannot complete the questionnaire by themselves. To guide recall period, children were asked to state the time period they refer to when commenting on the symptoms.
We interviewed children-caregivers pairs until saturation was reached and no new concepts were spontaneously brought up in 3 to 4 interviews when a planned interim analysis was performed. The first, after 17 interviews, led to a revision of the script to focus on issues not satisfactorily addressed in the first batch of interviews (eg, focus on children with more active disease and younger children). A second interim analysis was performed after 60 interviews, which led to another revision of the script focusing on the 9 prominent concepts, discussed in >10% of the interviews. Revisions also included comments received from the FDA and the EMA.
Analyses
All sites sent the interviews to the coordinating center at Shaare Zedek Medical Center as digital recordings with written case report forms. Interviews were transcribed; vocabulary phrases were tabulated according to the different strata using MAXQDA12 (VERBI GmbH, Berlin, Germany) software. Data are presented as mean AE standard deviation or counts (proportions), as appropriate. A priori, we excluded concepts identified by <10% of respondents. This study was approved by the ethics committee of all sites; an informed consent was received according to the institutional ethics approval.
RESULTS
A total of 79 interviews were performed; 30 paired childcaregiver interviews, 16 with the child only, and 3 with the caregiver only, totaling 46 interviews with children and 33 with caregivers. The duration of most interviews was 15 to 20 minutes. Basic characteristics were as expected from a typical pediatric cohort of UC with most patients having pancolitis ( Table 1) . Assessment of severity of the disease was similar whether captured by the children, caregivers, and the physician (Table 1) .
Concepts Identified by the Children
Interviews were transcribed and phrases grouped under shared items. Each item has been rated by importance and frequency of endorsement (supplementary Tables 1 and 2 , http:// links.lww.com/MPG/A682). The same process was repeated with the caregivers, focusing on behaviors of the child while experiencing the item (supplementary Tables 2 and 3 , http://links.lww.com/ MPG/A682). There was a general good agreement between the scoring of the children and their caregivers ( Table 2, supplementary  Table 2 , http://links.lww.com/MPG/A682, and Fig. 1 ). In the younger age group, there was a small difference between children's and caregivers' rating of abdominal pain, general well-being and nocturnal stool. In the older age group, there was some difference in the rating of rectal bleeding and a large difference in the rating of stool consistency.
According to the summary variable of importance X frequency (shown in parenthesis), the items were ranked in decreasing order of weights: abdominal pain (3.9), rectal bleeding (3.6), stool frequency (3.0), stool consistency (3.0), general well-being/fatigue (2.9), urgency (1.9), nocturnal stools (1.6), lack of appetite (1.1), and weight loss (0.6). Additional nonspecific symptoms were brought up, including headaches, dizziness, nausea, and bloating but in <10% of interviews.
Age Groups and Recall Period
Interviewers were asked to comment, via an open question, about the overall ability of the child to understand the concepts discussed in the interviews to guide the cutoff of the different TUMMY-UC age-appropriate versions. Three age groups were clearly identified: the youngest could not address to the questions independently, the middle age group could address simple-worded questions with some explanation, and the older age group could easily grasp concepts as adults (Table 3 ). Average recall period of children and their caregivers was 3 AE 2.6 and 3.6 AE 2.9 days, respectively. The period that the children with active disease at the time of interview were referring to was 3.8 AE 2.9 days.
DISCUSSION
In this first stage of the TUMMY-UC development, we identified and ranked signs and symptoms important to children and adolescents with UC. The same items were identified by both children and their caregivers in a similar decreasing order of importance and frequency: abdominal pain, rectal bleeding, stool frequency, stool consistency, general well-being/fatigue, urgency, nocturnal stools, loss of appetite, and weight loss. The latter 2 were ranked last, possibly because both may be attributed to factors other than disease-related factors and because these occur typically only when the disease is severe. Moreover, the use of steroids influences both factors in ways unrelated to the activity of the disease while increasing appetite and, by virtue of fluid accumulation, also weight.
Three different age groups were identified: the youngest ( 7 years old), in which children cannot complete the questionnaires independently, and thus an observer-reported questionnaire should be developed, the middle age group (8-12 years old), which can complete an easy questionnaire independently, and the older age group (>12 years old), which can easily grasp concepts as adults. These findings are compatible with previous studies showing that children >8 years of age were able to comprehend the majority of items and response options in different areas (15, 16) . Furthermore, the similarity between the rating of the children and Means AE SD and counts (%) are presented as appropriate. PUCAI ¼ Pediatric Ulcerative Colitis Activity Index.
Ã Scored on a 100-mm visual analogue scale.
TABLE 2. Ranking of concepts based on the summary importance Â frequency ratings, sort from high to low their caregivers was notable mainly in the younger age group. This is intuitive because younger children tend to share their experiences, including intimate habits, with their parents more often than older children. These findings lend support for developing an observer-reported outcome measure for children 7 years of age. According to the FDA, the observer may report behaviors associated with the measured concept, rather than the concept itself. For instance, observers can describe how their child is acting while experiencing abdominal pain, but they cannot comment directly on the degree of pain.
The signs and symptoms identified by the children to reflect their colitis include all 6 items of the PUCAI. This should come as a little surprise because the development of the PUCAI followed a rigorous iterative process of 48 international pediatric IBD experts experienced with interviewing children and who can easily identify key items discussed regularly by their patients (17) . Indeed, these items are also included in other available UC indices (5) . An attempt in adults to adapt the clinician-based Mayo score to a PRO has shown good initial results (18) .
This study involved a multicenter, multicultural enrolment to ensure generalization and cross-cultural diversity. The large sample size of the interviewed children was required to reach saturation in the replies. However, our study is not without limitations. Although we managed to balance a wide range of parameters, the youngest group was underrepresented. In the next interview stage of the TUMMY-UC development, an effort will be made to enroll younger patients and those with more active disease.
A reliable and valid PRO can facilitate globally accepted standardized outcome measures in pediatric UC in the era of the new regulatory requirements. Furthermore, cognitive interviews are underway to understand how the items identified here are being understood by children, to determine the exact wording of the items and their response options. The TUMMY-UC may be then used as a composite outcome with endoscopically proven mucosal healing, whereas the PUCAI, approximating mucosal inflammation, may be used when endoscopy is not warranted or feasible.
